// App-Quantinova.ai

TCTAP A-146 : First Report on the Procedural Safety and 6-Month Outcome of Patients Treated with 48mm Everolimus Eluting Stent

Researchers

Presenter

  • Mohd Kamal Mohd Arshad

Principal Investigators

  • Hee Hwa Ho

  • Paul JL Ong

Medical Centers

  • Tan Tock Seng Hospital, Novena, Singapore

Locations

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Angina

  • Dyslipidemia

  • Congestive heart failure

  • Hypertension

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved